Lung Cancer Trial, Recruiting NCT06404164 Sponsor: Guangdong Provincial People's Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06404164
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a small lung nodule of a specific size, where the nodule-to-chest ratio falls within defined limits based on nodule size (confirm with trial site for exact measurements)
  • People whose lung nodule is located in the outer two-thirds of the lung area
  • People whose case has been reviewed using 3D imaging technology to plan the surgical boundaries before any operation
  • People whose lung cancer has been clinically assessed as an early stage (Stage IA1 or IA2, using the eighth edition staging system) with no spread to lymph nodes or other parts of the body, and whose tumour is considered surgically removable

Who may not be able to join:

  • Cases where no surgical video recording exists, or where no post-surgery measurements and records of the removed tissue are available
  • Cases where the surgical cut edge does not extend beyond a distance equal to the nodule's diameter from the nodule itself
  • Cases where the area removed during surgery turns out to be more than 50% larger than what was planned beforehand
  • Cases where the pathology results after surgery show a stage other than IA1 or IA2 (pT1aN0M0 or pT1bN0M0, eighth edition)
  • Cases where the treating surgeon determines that a more extensive surgical removal is needed
  • People who have a chronic lung condition — such as COPD, pulmonary fibrosis, or silicosis — that is already causing, or is at risk of causing, further loss of lung function

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13609777314

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
30 January 2022
Est. completion
3 April 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Lung fuction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov